Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Advice programme 1 selected

Advice programme

Showing 51 to 68 of 68

TitleReference numberPublishedLast updated
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphateESUOM4
Prevention of chemotherapy induced nausea and vomiting in adults: netupitant/palonosetronESNM69
Prevention of recurrence of C3 glomerulopathy post-transplant: eculizumabESUOM44
Promoting tolerance of enteral feeds in children and young people: domperidoneESUOM18
Pulmonary sarcoidosis: infliximabES2
Refractory extrapulmonary sarcoidosis: infliximabES4
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitisES35
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritisES29
Restless legs syndrome: Oxycodone/naloxone prolonged releaseESNM67
Reversal of the anticoagulant effect of dabigatran: idarucizumabESNM73
Schizophrenia: lurasidoneESNM48
Schizophrenia: omega-3 fatty acid medicinesESUOM19
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromideES5
Skin involvement in systemic sclerosis: rituximabES7
Symptoms of peripheral arterial disease: ramiprilESUOM45
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo)ESNM65
Type 2 diabetes: insulin degludecESNM25
Type 2 diabetes: insulin degludec/liraglutide (Xultophy)ESNM60

Results per page

  1. 10
  2. 25
  3. 50
  4. All